PRA International Launches Project Assurancesm Campaign
CRO employs differentiated approach to clinical development service delivery
PRA International, Inc. (PRA), one of the world's leading clinical research organizations (CRO), launched a campaign defining its differentiated Project Assurance approach. The announcement will be made next week at the Drug Information Association's (DIA) 2004 Annual Meeting in Washington D.C.
Project Assurance and the accompanying tagline The Project Assurance Difference refer to PRA's ability to consistently plan and conduct fast and dependable clinical trials while delivering the right economic solution.
"Project Assurance is a promise to our clients that PRA will commit all of our resources to the success of every single trial we undertake," said President and CEO Pat Donnelly. "We've found that our company-wide, inter-office focus on individual project success has created a reliability that our clients value."
The backbone of Project Assurance is a global, unified communications infrastructure and a drive to continuously measure, refine, and leverage best practices.
"We have created a structure that prioritizes the role of our project managers and provides them with unprecedented access to every PRA resource," remarked David Dockhorn, Executive Vice President of Global Operations. "Whether across an ocean or in the executive boardroom, our collective expertise fully supports the project managers' ability to achieve each of our clients' goals."
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
